| ★ | GP-SOD Plus Targeted Phototherapy Improves Vitiligo Repigmentation | | 249 | Estados Unidos | |
| 17 | Furoscix ReadyFlow (Furosemide) and its Impact on HF, CKD Edema Treatment | | 374 | Estados Unidos | 65 |
| 2 | Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD | ATS 2026 | | 301 | Estados Unidos | 70 |
| 6 | Hair Loss Update 2026: JAK Inhibitors, Oral Minoxidil, and Sequencing | | 209 | Estados Unidos | 68 |
| 9 | Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD | | 152 | Estados Unidos | 67 |
| 7 | FIND-CKD Trial Poses Finerenone as a "Third Pillar" for Nondiabetic CKD | | 123 | Estados Unidos | 68 |
| 10 | PROACTIVE-HF: Cordella PA Sensor Improves HF Status Regardless of EF | | 100 | Estados Unidos | 67 |
| 13 | Phase 3b Data on Ixekizumab, Tirzepatide for Psoriasis and Overweight, With Mark Lebwohl, MD | | 88 | Estados Unidos | 66 |
| 14 | SYMPHONY-PE: Early Thrombectomy Improves Pulmonary Embolism Outcomes | | 86 | Estados Unidos | 66 |
| 3 | Omalizumab vs Oral Immunotherapy for Multifood Allergy | | 65 | Estados Unidos | 70 |
| 1 | GP-SOD Plus Targeted Phototherapy for Vitiligo: Safety, Dosing, Next Steps | | 60 | Estados Unidos | 85 |
| 15 | How Well-Being in Psoriasis is Being Assessed Via WHO-5, With Ulrich Mrowietz, MD | | 56 | Estados Unidos | 66 |
| 8 | Mifepristone Improves HbA1c, Weight in Poorly Controlled T2D, Regardless of GLP-1 Treatment | | 46 | Estados Unidos | 67 |
| 5 | Plaque Imaging and the TRANSFORM Trial in Myocardial Infarction | | 29 | Estados Unidos | 68 |
| 19 | Pegtarazimod Cuts Oxygen Need in Hospitalized COPD Patients | ATS 2026 | Gerald Criner, MD | | 29 | Estados Unidos | 65 |
| 16 | Why Quality of Life Can't Take a Back Seat in ISM: Thanai Pongdee, MD, on New PIONEER Data | | 27 | Estados Unidos | 65 |
| 12 | Key Non-Medication Clinical Pearls for Dermatologists, With Matthew Zirwas, MD | | 21 | Estados Unidos | 66 |
| 18 | Abdominal Pain and Bloating: Recognizing HAE, MCAS, and Eosinophilic GI Disorders | Brian Lacy, MD | | 20 | Estados Unidos | 65 |
| 11 | Are You Misdiagnosing Atopic Dermatitis? Matthew Zirwas, MD, on Adult-Onset AD | | 19 | Estados Unidos | 66 |
| 20 | How ABCG2 Inhibition Could Change EPP Disease Management | | 17 | Estados Unidos | 65 |
| 4 | What's Next for Peanut Allergy Microneedle Immunotherapy, With Brian Vickery, MD | | 12 | Estados Unidos | 69 |